Zenas BioPharma, Inc. (ZBIO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Zenas BioPharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -4.30x | -2.18x | -18.55x | -5.77x |
| P/B Ratio | 6.71x | 1.10x | -3.05x | -3.58x |
| P/S Ratio | 162.41x | 68.44x | 13.77x | 0.00x |
| Profitability | ||||
| Gross Margin | 100.0% | -2682.8% | 100.0% | 0.0% |
| Operating Margin | -2113.8% | -3277.8% | -74.3% | 0.0% |
| Net Margin | -3777.4% | -3139.8% | -74.2% | 0.0% |
| EBITDA Margin | -3704.3% | -3275.0% | -54.1% | 0.0% |
| Liquidity | ||||
| Current Ratio | 5.61x | 6.21x | 2.57x | 2.64x |
| Quick Ratio | 5.61x | 6.21x | 2.57x | 2.64x |
| Leverage | ||||
| Debt/Equity | 0.33x | 0.00x | -0.09x | -0.01x |
YoY = year-over-year change. Source: FMP..